日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Low- and standard-dose peginterferon alfa-2a for chronic hepatitis C, genotype 2 or 3: efficacy, tolerability, viral kinetics and cytokine response.

低剂量和标准剂量聚乙二醇干扰素α-2a治疗慢性丙型肝炎(基因型2或3):疗效、耐受性、病毒动力学和细胞因子反应

Rotman Y, Borg B B, Soza A, Feld J J, Modi A A, Loomba R, Lutchman G, Rivera E, Doo E, Ghany M G, Heller T, Neumann A U, Liang T J, Hoofnagle J H

Changes in anti-viral effectiveness of interferon after dose reduction in chronic hepatitis C patients: a case control study

慢性丙型肝炎患者减少干扰素剂量后抗病毒疗效的变化:一项病例对照研究

Bekkering, F C; Neumann, A U; Brouwer, J T; Levi-Drummer, R S; Schalm, S W

Interferon resistance of hepatitis C virus genotype 1b: relationship to nonstructural 5A gene quasispecies mutations

丙型肝炎病毒1b基因型的干扰素耐药性:与非结构蛋白5A基因准种突变的关系

Pawlotsky, J M; Germanidis, G; Neumann, A U; Pellerin, M; Frainais, P O; Dhumeaux, D

Slower evolution of human immunodeficiency virus type 1 quasispecies during progression to AIDS

人类免疫缺陷病毒1型准种在发展为艾滋病过程中进化速度较慢

Delwart, E L; Pan, H; Sheppard, H W; Wolpert, D; Neumann, A U; Korber, B; Mullins, J I